These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


453 related items for PubMed ID: 15811197

  • 1. Diabetic dyslipidaemia: insights for optimizing patient management.
    Vergès B.
    Curr Med Res Opin; 2005; 21 Suppl 1():S29-40. PubMed ID: 15811197
    [Abstract] [Full Text] [Related]

  • 2. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 3. Diabetes and cardiovascular risk markers.
    Erdmann E.
    Curr Med Res Opin; 2005 Nov; 21 Suppl 1():S21-8. PubMed ID: 15811196
    [Abstract] [Full Text] [Related]

  • 4. Therapies for diabetic dyslipidaemia.
    Bell DS, Al Badarin F, O'Keefe JH.
    Diabetes Obes Metab; 2011 Apr; 13(4):313-25. PubMed ID: 21205114
    [Abstract] [Full Text] [Related]

  • 5. Interpreting clinical trials of diabetic dyslipidaemia: new insights.
    Wierzbicki AS.
    Diabetes Obes Metab; 2009 Mar; 11(3):261-70. PubMed ID: 17645560
    [Abstract] [Full Text] [Related]

  • 6. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B, Maes M, Zambon A.
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C, Olsson AG.
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PPAR agonists in the treatment of insulin resistance and associated arterial disease.
    Camejo G.
    Int J Clin Pract Suppl; 2003 Mar; (134):36-44. PubMed ID: 12793596
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Dyslipidaemia and diabetes mellitus].
    Ducobu J.
    Rev Med Liege; 2005 Mar; 60(5-6):578-85. PubMed ID: 16035331
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus.
    Cavender MA, Lincoff AM.
    Am J Cardiovasc Drugs; 2010 Mar; 10(4):209-16. PubMed ID: 20653327
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.